Bizarre Patents
A hand wearable body squeegee comprising a glove portion, a concave squeegee band, and a linear squeegee band.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6548042 | Bis-phosphonate compounds The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I ##STR1## wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a link... | 04/15/2003 |
| 6541478 | Smoking cessation treatments using naltrexone and related compounds Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrex... | 04/01/2003 |
| 6500857 | Subcutaneous muscle treatment using electronic stimulation and topical compositions Aging and sagging subcutaneous muscles are treated by first applying a composition containing at least one acetylcholine precursor and/or at least one compound exhibiting catecholamine activity to the overlying skin area, and then electronically stimulati... | 12/31/2002 |
| 6492131 | Class I-type lysyl-TRNA synthetase A protein with canonical lysyl-tRNA synthetase activity was purified from Methanococcus maripaludis, cloned, and sequenced. The predicted amino acid sequence of the enzyme indicated a novel class I polypeptide structurally unrelated to class II lysyl-tRNA... | 12/10/2002 |
| 6437004 | Treatment of skin damage using olive oil polyphenols Free radical-scavenging olive oil polyphenols are topically applied to treat skin damage, such as contact dermatitis (particularly diaper area dermatitis), atopic dermatitis, xerosis, eczema (including severe hand and foot eczema), rosacea, seborrhea, pso... | 08/20/2002 |
| 6429018 | Prenatal screening for Down's syndrome using hyperglycosylated gonadotropin A prenatal screening method for Down's syndrome involves assaying for hyperglycosylated gonadotropin in biological test samples such as urine, plasma or serum obtained from pregnant women. Hyperglycosylated gonadotropin comprises a variant population of c... | 08/06/2002 |
| 6417226 | Skin whiteners containing hydroxytetronic acid Skin whitening compositions contain -hydroxytetronic acid or a -hydroxy tetronic derivative, and, in some cases, hydroquinone, an -hydroxy acid such as glycolic acid, and a fatty acid ester of ascorbic acid such as ascorbyl palmitate.... | 07/09/2002 |
| 6365623 | Treatment of acne using lipoic acid Active acne and acneiform scars are treated by topical application of a composition containing lipoic acid and/or a lipoic acid derivative such as dihydrolipoic acid, a lipoic or dihydrolipoic acid ester, a lipoic or dihydrolipoic acid amide, a lipoic or ... | 04/02/2002 |
| 6319942 | Topical scar treatments using alkanolamines Cutaneous scars are reduced by the topical application of compositions containing an alkanolamine such as ethylaminoethanol, methylaminoethanol, dimethylaminoethanol, isopropanolamine, triethanolamine, isopropanoldimethylamine, ethylethanolamine, 2-butano... | 11/20/2001 |
| 6296861 | Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters A synergistic combination of conjugated linoleic acid and fatty acid esters of ascorbic acid is topically applied to treat skin damage, such as contact dermatitis, atopic dermatitis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation bu... | 10/02/2001 |
| 6287563 | Therapeutic agents and autoimmune diseases There is disclosed the use, as an agent in the treatment or the prevention of an autoimmune disease, of: (i) an agent having GM-1 binding activity, other than Ctx or Etx, or the B subunits of Ctx and Etx; or (ii) an agent having an effect on GM-1 mediated intr... | 09/11/2001 |
| 6274633 | NMDA antagonist The present invention relates to the use of xenon as an NMDA antagonist. In particular, the invention relates to a method of treatment comprising modulating the activity of an NMDA receptor in a mammal, the method comprising modulating the activity of the... | 08/14/2001 |
| 6252045 | Human occludin, its uses and enhancement of drug absorption using occludin inhibitors The gene for occludin, an integral transmembrane protein specifically associated with tight junctions that functions in forming intercellular seal, is cloned, characterized, and sequenced, and the polypeptide sequence determined. Drug delivery is enhanced... | 06/26/2001 |
| 6218673 | Optical scanning tomography for three-dimensional dosimetry and imaging of energy fields An optical scanner gives three dimensional dosimetric data by scanning, with at least one light beam, a translucent medium exhibiting optical properties which change upon receipt of radiant energy representing a dose distribution of the energy. At least o... | 04/17/2001 |
| 6191121 | Treatment of skin damage using polyenylphosphatidylcholine Polyenylphosphatidylcholine is topically applied to treat skin damage, such as contact dermatitis (particularly diaper area dermatitis), atopic dermatitis, xerosis, eczema (including severe hand and foot eczema), rosacea, seborrhea, psoriasis, thermal and... | 02/20/2001 |
| 6140470 | Human monoclonal anti-tumor antibodies Human monoclonal anti-tumor antibodies are isolated from fusion phage single-chain Fv and VH antibody libraries constructed from the peripheral blood lymphocytes of immunized cancer patients. Antibodies that bind to tumor cells of the same kind... | 10/31/2000 |
| 6036958 | Tsetse thrombin inhibitor A potent and specific inhibitor of thrombin is purified from salivary gland extracts of the tsetse fly, Glossina morsitans morsitans. The inhibitor has a molecular weight of 3530 Daltons as determined by laser desorption mass spectroscopy. The inhibitor i... | 03/14/2000 |
| 6037468 | Glycosylated indolocarbazole synthesis Tertiary alcohols containing the structural features illustrated in 3 or 4 below (Scheme I) are prepared by reacting at least one diazo carbonyl compound, e.g., 1 in Scheme I) and at least one allylic alcohol (e.g., 2 in Scheme I) in a coupling reaction r... | 03/14/2000 |
| 6004970 | Smoking cessation treatments using naltrexone and related compounds Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrex... | 12/21/1999 |
| 5635370 | DNA encoding BEHAB, a brain hyaluronan-binding protein, and recombinant expression systems for production of BEHAB polypeptides A gene encoding mammalian brain enriched hyaluronan binding (BEHAB) protein is isolated and characterized from brain tissue and found to have a high degree of sequence homology to members of the proteoglycan tandem repeat family of hyaluronan binding prot... | 06/03/1997 |
| 5427937 | Hookworm anticoagulant A soluble anticoagulant protein isolated and purified from Ancylostoma hookworms markedly prolongs both the prothrombin time and partial thromboplastin time in clotting assays. The protein has an apparent molecular weight of about 6500 daltons and exhibit... | 06/27/1995 |
